14 results
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
Therapy - Evidence Summary ... Trials - EGDT: NEJM ... - ProCESS: NEJM ... - ProMlSe: NEJM ... Therapy #Trials #EBM
Suspected sepsis: Summary of NICE guidlelines #Diagnosis #Management #EM #IM #PrimaryCare #Sepsis #NICE #Monitoring #BMJ
Suspected sepsis: Summary ... Diagnosis #Management #EM ... #IM #PrimaryCare
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Trials and Evidence Summary ... Care TRICC - NEJM ... - ICU FOCUS - NEJM ... UGIB TRISS - NEJM ... /vmoitra) #EBM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Nonvertebral Fracture #EBM ... PrimaryCare #Endo #IM ... #Alendronate #NEJM
Summary of the 10 Most Common Histopathological Diagnoses among 9523 Patients Who Underwent Epilepsy Surgery. #Diagnosis
Summary of the 10 ... #Diagnosis #EBM ... #Differential #NEJM
Cullen's sign. Lipase 1,781. Bruising in the skin around the umbilicus. This sign is named after
In summary, Cullen's ... #cullensign #em ... #peritonitis #IM